Doug Hayden
- Psychiatry and Mental health top 1%
- Physiology top 5%
- Molecular Biology
- Endocrinology, Diabetes and Metabolism top 2%
- Pharmacology top 5%
- Co-authors
- David C. HendersonDavid SchoenfeldEnrico CaglieroDonald GoffC. H. GRAYChristina P. C. BorbaPaul M. CopelandDavid M. Nathan
- Topics
- Schizophrenia research and treatment (10 papers)Diet and metabolism studies (5 papers)Respiratory Support and Mechanisms (3 papers)
- Partner nations
- United States
In The Last Decade
Doug Hayden
24 papers receiving 2.5k citations
Hit Papers
Peers
Comparison fields: 5 of 119
- Psychiatry and Mental health 1.1k
- Physiology 758
- Molecular Biology 537
- Endocrinology, Diabetes and Metabolism 534
- Pharmacology 287
Countries citing papers authored by Doug Hayden
This map shows the geographic impact of Doug Hayden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Doug Hayden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Doug Hayden more than expected).
Fields of papers citing papers by Doug Hayden
This network shows the impact of papers produced by Doug Hayden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Doug Hayden. The network helps show where Doug Hayden may publish in the future.
Co-authorship network of co-authors of Doug Hayden
This figure shows the co-authorship network connecting the top 25 collaborators of Doug Hayden. A scholar is included among the top collaborators of Doug Hayden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Doug Hayden. Doug Hayden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 46 | |
| 2 | 104 | |
| 3 | 26 | |
| 4 | 40 | |
| 5 | 44 | |
| 6 | 52 | |
| 7 | 262 | |
| 8 | 15 | |
| 9 | 163 | |
| 10 | 98 | |
| 11 | 66 | |
| 12 | 164 | |
| 13 | 30 | |
| 14 | 22 | |
| 15 | 69 | |
| 16 | 35 | |
| 17 | 61 | |
| 18 | Clozapine, Diabetes Mellitus, Weight Gain, and Lipid Abnormalities: A Five-Year Naturalistic Studybreakdown → | 558 |
| 19 | 262 | |
| 20 | 342 |
About Doug Hayden
Doug Hayden is a scholar working on Psychiatry and Mental health, Pharmacy and Health Information Management, having authored 25 papers that have together received 2.7k indexed citations. Recurring topics across this work include Schizophrenia research and treatment (10 papers), Diet and metabolism studies (5 papers) and Respiratory Support and Mechanisms (3 papers). The work is most often cited by research in Psychiatry and Mental health (1.1k citations), Biological Psychiatry (184 citations) and Endocrinology, Diabetes and Metabolism (534 citations). Doug Hayden has collaborated with scholars based in United States. Frequent co-authors include David C. Henderson, David Schoenfeld, Enrico Cagliero, Donald Goff, C. H. GRAY, Christina P. C. Borba, Paul M. Copeland, David M. Nathan, A. Eden Evins and Linda M. Delahanty. Their work appears in journals such as Journal of the American College of Cardiology, American Journal of Psychiatry and Neurology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.